PortfoliosLab logoPortfoliosLab logo
UMBF vs. ZYME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UMBF vs. ZYME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UMB Financial Corporation (UMBF) and Zymeworks Inc. (ZYME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UMBF achieves a 12.73% return, which is significantly higher than ZYME's -8.43% return.


UMBF

1D
0.81%
1M
-0.04%
YTD
12.73%
6M
17.27%
1Y
28.36%
3Y*
28.87%
5Y*
7.52%
10Y*
10.27%

ZYME

1D
-1.75%
1M
-9.39%
YTD
-8.43%
6M
-3.94%
1Y
107.13%
3Y*
40.62%
5Y*
-5.09%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

UMBF vs. ZYME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UMBF
UMB Financial Corporation
12.73%3.44%37.34%2.21%-19.97%56.04%2.64%14.71%-13.86%0.34%
ZYME
Zymeworks Inc.
-8.43%79.85%40.90%32.19%-52.04%-65.32%3.96%209.67%93.33%-41.59%

Correlation

The correlation between UMBF and ZYME is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (All Time)
Calculated using the full available price history since May 1, 2017

0.17

Fundamentals

EPS

UMBF:

$15.48

ZYME:

-$583.41

PS Ratio

UMBF:

1.65

ZYME:

23.17

Total Revenue (TTM)

UMBF:

$4.46B

ZYME:

$78.86M

Gross Profit (TTM)

UMBF:

$1.99B

ZYME:

$77.16M

EBITDA (TTM)

UMBF:

$937.72M

ZYME:

-$47.18B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UMBF vs. ZYME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UMBF
UMBF Risk / Return Rank: 6868
Overall Rank
UMBF Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
UMBF Sortino Ratio Rank: 6565
Sortino Ratio Rank
UMBF Omega Ratio Rank: 6666
Omega Ratio Rank
UMBF Calmar Ratio Rank: 6767
Calmar Ratio Rank
UMBF Martin Ratio Rank: 6767
Martin Ratio Rank

ZYME
ZYME Risk / Return Rank: 8888
Overall Rank
ZYME Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
ZYME Sortino Ratio Rank: 8787
Sortino Ratio Rank
ZYME Omega Ratio Rank: 8585
Omega Ratio Rank
ZYME Calmar Ratio Rank: 9292
Calmar Ratio Rank
ZYME Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UMBF vs. ZYME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UMB Financial Corporation (UMBF) and Zymeworks Inc. (ZYME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UMBFZYMEDifference

Sharpe ratio

Return per unit of total volatility

1.06

2.03

-0.97

Sortino ratio

Return per unit of downside risk

1.54

2.99

-1.45

Omega ratio

Gain probability vs. loss probability

1.21

1.36

-0.16

Calmar ratio

Return relative to maximum drawdown

1.46

5.47

-4.01

Martin ratio

Return relative to average drawdown

3.37

12.23

-8.86

UMBF vs. ZYME - Sharpe Ratio Comparison

The current UMBF Sharpe Ratio is 1.06, which is lower than the ZYME Sharpe Ratio of 2.03. The chart below compares the historical Sharpe Ratios of UMBF and ZYME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UMBFZYMEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.06

2.03

-0.97

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.23

-0.08

+0.31

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.11

+0.15

Drawdowns

UMBF vs. ZYME - Drawdown Comparison

The maximum UMBF drawdown since its inception was -52.70%, smaller than the maximum ZYME drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for UMBF and ZYME.


Loading charts...

Drawdown Indicators


UMBFZYMEDifference

Max Drawdown

Largest peak-to-trough decline

-52.70%

-91.81%

+39.11%

Max Drawdown (1Y)

Largest decline over 1 year

-18.57%

-20.28%

+1.71%

Max Drawdown (3Y)

Largest decline over 3 years

-31.80%

-45.75%

+13.95%

Max Drawdown (5Y)

Largest decline over 5 years

-50.25%

-87.84%

+37.59%

Max Drawdown (10Y)

Largest decline over 10 years

-50.25%

Current Drawdown

Current decline from peak

-3.87%

-57.56%

+53.69%

Average Drawdown

Average peak-to-trough decline

-17.77%

-52.42%

+34.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.05%

9.07%

-1.02%

Volatility

UMBF vs. ZYME - Volatility Comparison

The current volatility for UMB Financial Corporation (UMBF) is 7.44%, while Zymeworks Inc. (ZYME) has a volatility of 14.09%. This indicates that UMBF experiences smaller price fluctuations and is considered to be less risky than ZYME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UMBFZYMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.44%

14.09%

-6.65%

Volatility (6M)

Calculated over the trailing 6-month period

18.56%

29.62%

-11.06%

Volatility (1Y)

Calculated over the trailing 1-year period

26.95%

53.13%

-26.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.30%

61.94%

-28.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.52%

61.57%

-28.05%

Dividends

UMBF vs. ZYME - Dividend Comparison

UMBF's dividend yield for the trailing twelve months is around 1.28%, while ZYME has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
UMBF
UMB Financial Corporation
1.28%1.42%1.39%1.83%1.78%1.30%1.81%1.76%1.92%1.45%1.28%2.04%
ZYME
Zymeworks Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

UMBF vs. ZYME - Financials Comparison

This section allows you to compare key financial metrics between UMB Financial Corporation and Zymeworks Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
867.07M
0
(UMBF) Total Revenue
(ZYME) Total Revenue
Values in USD except per share items

Frequently Asked Questions


UMBF and ZYME have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZYME has higher volatility (14.09%) compared to UMBF (7.44%). In terms of maximum drawdown, UMBF dropped -52.70% vs ZYME's -91.81%.

ZYME currently has the higher Sharpe Ratio (2.03 vs 1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UMBF and ZYME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer